Supreme Court Rejects Pharma Appeals [titlebase] – Medicare Negotiations Stay on Track
West Wood blvd – 18 May 2026 | In a decisive move that will shape the future of prescription drug pricing, the Supreme Court Rejects pharma appeals [titlebase] and leaves the Medicare drug price negotiation program untouched. The high court declined to hear challenges brought by several of the nation’s largest drugmakers, including AstraZeneca, Boehringer … Read more